In Vitro and In Vivo Efficacy of a Stroma-Targeted, Tumor Microenvironment Responsive Oncolytic Adenovirus in Different Preclinical Models of Cancer

More than one million women are diagnosed annually worldwide with a gynecological cancer. Most gynecological cancers are diagnosed at a late stage, either because a lack of symptoms, such as in ovarian cancer or limited accessibility to primary prevention in low-resource countries, such as in cervic...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfano, Ana, Cafferata, Eduardo G. A., Gangemi, Mariela, Nicola Candia, Alejandro, Malnero, Cristian M., Bermudez, Ismael, Lopez, Mauricio Vargas, Ríos, Gregorio David, Rotondaro, Cecilia, Cuneo, Nicasio, Curiel, David T., Podhajcer, Osvaldo L., Lopez, Maria Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297998/
https://www.ncbi.nlm.nih.gov/pubmed/37373140
http://dx.doi.org/10.3390/ijms24129992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297998/
https://www.ncbi.nlm.nih.gov/pubmed/37373140
http://dx.doi.org/10.3390/ijms24129992

Ejemplares similares